MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Read More…
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
Phone703-251-8500
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.39 billion
Profitability
Miscellaneous
Employees18,600
Next Earnings Date11/19/2019 (Estimated)
OptionableOptionable
MAXIMUS (NYSE:MMS) Frequently Asked Questions
What is MAXIMUS's stock symbol?
MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."
How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?
MAXIMUS announced a quarterly dividend on Thursday, October 10th. Investors of record on Friday, November 15th will be paid a dividend of $0.28 per share on Friday, November 29th. This represents a $1.12 annualized dividend and a yield of 1.49%. The ex-dividend date is Thursday, November 14th. This is a boost from MAXIMUS's previous quarterly dividend of $0.25. View MAXIMUS's Dividend History.
How will MAXIMUS's stock buyback program work?
MAXIMUS announced that its Board of Directors has approved a stock buyback program on Monday, June 25th 2018, which allows the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to purchase up to 4.9% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board of directors believes its stock is undervalued.
How were MAXIMUS's earnings last quarter?
MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings results on Thursday, August, 8th. The health services provider reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.04. The health services provider had revenue of $730.70 million for the quarter, compared to the consensus estimate of $754.81 million. MAXIMUS had a return on equity of 20.72% and a net margin of 8.44%. The firm's quarterly revenue was up 22.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.91 earnings per share. View MAXIMUS's Earnings History.
When is MAXIMUS's next earnings date?
What guidance has MAXIMUS issued on next quarter's earnings?
MAXIMUS updated its FY19 earnings guidance on Thursday, August, 8th. The company provided EPS guidance of $3.70-3.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.70. The company issued revenue guidance of $2.92 billion, compared to the consensus revenue estimate of prior $3.65-3.75.
What price target have analysts set for MMS?
2 Wall Street analysts have issued 1 year price objectives for MAXIMUS's shares. Their forecasts range from $77.00 to $83.00. On average, they anticipate MAXIMUS's share price to reach $80.00 in the next twelve months. This suggests a possible upside of 6.4% from the stock's current price. View Analyst Price Targets for MAXIMUS.
What is the consensus analysts' recommendation for MAXIMUS?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.
Has MAXIMUS been receiving favorable news coverage?
Media coverage about MMS stock has been trending very negative this week, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. MAXIMUS earned a news impact score of -3.2 on InfoTrie's scale. They also assigned news coverage about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for MAXIMUS.
Are investors shorting MAXIMUS?
MAXIMUS saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 1,330,000 shares, a drop of 17.4% from the August 30th total of 1,610,000 shares. Based on an average trading volume of 310,500 shares, the short-interest ratio is currently 4.3 days. Currently, 2.1% of the shares of the company are sold short. View MAXIMUS's Current Options Chain.
Who are some of MAXIMUS's key competitors?
Some companies that are related to MAXIMUS include Msci (MSCI), Ctrip.Com International (CTRP), Akamai Technologies (AKAM), Broadridge Financial Solutions (BR), LYFT (LYFT), The Western Union (WU), WEX (WEX), Fair Isaac (FICO), Nielsen (NLSN), Etsy (ETSY), Zillow Group (Z), Zillow Group (ZG), Alliance Data Systems (ADS), CDK Global (CDK) and GrubHub (GRUB).
What other stocks do shareholders of MAXIMUS own?
Who are MAXIMUS's key executives?
MAXIMUS's management team includes the folowing people:
- Mr. Bruce L. Caswell, Pres, CEO & Director (Age 52)
- Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 67)
- Mr. Richard J. Nadeau, CFO & Treasurer (Age 64)
- Mr. David R. Francis, Gen. Counsel & Sec. (Age 58)
- Mr. Mark S. Andrekovich, Chief of Human Capital and Former Pres of Tax & Employer Services (Age 57)
Who are MAXIMUS's major shareholders?
MAXIMUS's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (0.75%), Rowland & Co. Investment Counsel ADV (0.04%), Pacer Advisors Inc. (0.04%), Bowling Portfolio Management LLC (0.03%), State of Alaska Department of Revenue (0.02%) and Assenagon Asset Management S.A. (0.02%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.
Which major investors are selling MAXIMUS stock?
MMS stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Pacer Advisors Inc. and Crossmark Global Holdings Inc.. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.
Which major investors are buying MAXIMUS stock?
MMS stock was bought by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, State of Alaska Department of Revenue, Assenagon Asset Management S.A., Camelot Portfolios LLC, Rowland & Co. Investment Counsel ADV, Signaturefd LLC and Cim LLC. View Insider Buying and Selling for MAXIMUS.
How do I buy shares of MAXIMUS?
Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is MAXIMUS's stock price today?
One share of MMS stock can currently be purchased for approximately $75.21.
How big of a company is MAXIMUS?
MAXIMUS has a market capitalization of $4.80 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.View Additional Information About MAXIMUS.
What is MAXIMUS's official website?
How can I contact MAXIMUS?
MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]
MarketBeat Community Rating for MAXIMUS (NYSE MMS)
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
